期刊文献+

妇科围术期静脉血栓形成的危险因素评估 被引量:8

The evaluation of risk factors of gynechologic perioperative venous thromboembolic
原文传递
导出
摘要 目的探讨妇科围术期静脉血栓形成的危险因素。方法回顾分析1 970例北京大学深圳医院妇科术后患者临床资料,采用统计学方法分析患者存在的危险因素与静脉血栓形成的关系。结果 1 970例手术患者中,发病患者13例,发病率为0.7%。其中,恶性肿瘤患者发病11例,占84.6%。单因素分析中,患者年龄、糖尿病、恶性肿瘤、肿瘤期别、深间质浸润、分化程度、肿瘤转移、手术方式、手术时间、术中出血量、输血与患者静脉血栓发生有关,差异有统计学意义(P<0.05)。多因素分析中,恶性肿瘤晚期、低分化是静脉血栓形成的相关危险因素,差异有统计学意义(P<0.05)。结论年龄及糖尿病史、恶性肿瘤、手术情况与围术期静脉血栓形成有密切关系,肿瘤分期及分化程度可能是静脉血栓形成的独立危险因素。 Objective To investigate the related risk factors of patients with venous thromboembolism perio- peration. Methods Data of 1 970 cases who underwent gynecologic surgery in Peking University Shenzhen Hospital was analyzed retrospectively. The risk factors were analyzed stitistically. Results Of the 1 970 cases, there were 13 cases developing venous thromboembolism. The total incidence was 0. 7%. Among the 13 cases, 11 were malig- nant tumor, accounting for 84.6%. Univariate analysis revealed that age, diabetes mellitus, malignant tumor (in- cluding tumor stage, deep stromal invasion, tumor grade, vascular invasion, tumor metastasis), operative type, op- erative time, blood loss, blood transfusion were related to perioperative venous thromboembosis (P〈0.05). In the Multivariate analysis, the advanced stage of tumor and poor differentiation had statistically significant differences (P〈0.05). Conclusions The age, diabetes mellitus, cancer and surgeries were related to the venous thromboem- bolism. In addition, stage of tumor and differentiation were independent risk factors of venous thromboembolism in gynecology.
出处 《中国妇产科临床杂志》 CSCD 北大核心 2015年第1期40-42,共3页 Chinese Journal of Clinical Obstetrics and Gynecology
基金 深圳市科技创新项目(201302060)
关键词 静脉血栓栓塞 围术期 危险因素 妇科 venous thromboembolism perioperation risk factors gynecology
  • 相关文献

参考文献9

  • 1Reitsma PH, Versteeg HH, Middeldorp S. Mechanistic view of risk factors for venous thromboembolism. Arterioscler Thromb Vasc Biol, 2012, 32: 563-568.
  • 2Gary HL, Alok AN, Nicole MK, et al. Venous thromboem- bolism prophylaxis and treatment in patients with cancer: A- merican Society of Clinical Onc01ogy Practice Guideline Up- date. J ClinOncol, 2013, 31: 2189-2204.
  • 3Rahn DD, Mamik MM, Sanses TV, et al. Society of Gyne- cologic Surgeons Systematic Review Group. Venous throm- boembolism prophylaxis in gynecologic surgery: a systematic review. Obstet Gyneeol, 2011, 118: 1111-1125.
  • 4Rosenberg D, Eiehorn A, Alarcon M, et al. Validating the IMPROVE Venous Thromboembolism (VTE) Risk Score: Retrospective Analysis of Electronic Data From a Large Health System. Chest, 2014, 145 (3 Suppl): 522A.
  • 5Diao D, Wang Z, Cheng Y, et al. D- dimer: not just an in- dicator of venous thrombosis but a predictor of asymptomatic hematogenous metastasis in gastric cancer patients. PLoS One, 2014, 9: e101125.
  • 6许琦,王悦,李艺,崔恒,王建六.妇科恶性肿瘤患者术后静脉血栓栓塞的高危因素分析[J].现代妇产科进展,2012,21(5):337-341. 被引量:21
  • 7Montoya TI, Leclaire EL, Oakley SH, et al. Venous throm- boembolism in women undergoing pelvic reconstructive sur- gery with mechanical prophylaxis alone. Int Urogynecol J, 2014, 25: 921-926.
  • 8Sandadi S, Lee S, Walter A, et al. Incidence of venous thromboembolism after minimally invasive surgery in patients with newly diagnosed endometrial cancer. Ohstet Gynecol, 2012, 120: 1077-1083.
  • 9Tollefson MK, Karnes RJ, Rangel L, et al. Blood type, lymphadenectomy and blood transfusion predict venous thromboembolic events following radical prostatectomy with pelvic lymphadenectomy. J Urol, 2014, 191: 646-651.

二级参考文献15

  • 1Wagman L, Baird M, Bennett C, et al. Venous thromboem- bolic disease. NCCN. Clinical practice guidelines in oncol- ogy[J]. J Natl Canc Netw,2008,6(8):716-753.
  • 2Kearon C, Kahn S, Agnelli G, et al. Antithrombotic thera- py for venous thromboembolic disease:American College of Chest Physicians Evidence-Based Clinical Practice Guidelines ( 8 th ed) [ J ]. Chest, 2008,133 ( 6 ) :454-545.
  • 3Kinjuh S,Albertsson M, Eskilsson J, et al. Antithrombotic treatment in protection against thrombogenic effects of 5- fluorouracil on vascular endothelium: a Scanning Micros- copy evaluation[ J]. Scanning,2001,23 ( 1 ) : 1-8.
  • 4Gobel U, Ebell W, Jurgens H, et al. Coagulation changes following bleomycin treatment in animals [ J]- Proc Am Soc Clin Oncol, 1983,2( 1 ) :39.
  • 5Wang J, Weiss I, Svoboda K, et al. Thrombogenic role of cells undergoing apoptosis [ J ]. Br J Haematol, 2001 , 115 (2) :382- 391.
  • 6Togna G, Togna A, Franconi M, et al. Cisplatin triggers platelet activation [ J]. Thromb Res, 2000,99 ( 5 ) : 503- 509.
  • 7Geerts W, Pineo G, Heit J, et al. Prevention of venous thromboembolism:the seventh ACCP conference on an- tithrombotic and thrombolytic therapy [ J ]. Chest, 2004, 126(3) :338-400.
  • 8Geerts W, Pineo G, Heit J, et al. NICE guidelines on re- ducing the risk of venous thromboembolism ( deep vein thrombosis and pulmonary embolism) in patients undergo- ing surgery [ J ]. J Orthopaedic Nursing, 2007, 11 ( 3 ) : 169-176.
  • 9Lee A, Levine M. The thrombophilic state induced by therapeutic agents in cancer patients [ J ]. Semin Thromb Hemost, 1999,25 ( 2 ) : 137-145.
  • 10Anonymous. Prevention of deep vein thrombosis and pul- monary embolism [ J]. Obstet Gynecol, 2007,110 ( 2 ) : 429 -440.

共引文献20

同被引文献80

引证文献8

二级引证文献78

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部